The question behind the half-year numbers
B.P. Marsh & Partners (LSE:BPM) has spent the past week in the news because of its founder's share sale, but the more durable question for shareholders sits in the half-year results published on 20 October 2026. Those figures, for the six months to 31 July 2026, show how heavily the group's net asset value now depends on a small number of investee businesses.
This article draws on that interim statement. No new trading information has been published since; the TR-1 filed on 11 November 2026 recorded Brian Marsh's holding falling to 30.30% of voting rights after the secondary sale, which does not change the portfolio.
Three holdings, most of the value
Group NAV was £372.2m at 31 July 2026, or 1,048.5p per share undiluted and 996.0p fully diluted, up from £360.2m at 31 January after £13.0m of dividends and £1.2m of buybacks. The share portfolio was valued at £296.5m.
Within that, Pantheon Specialty Group, the London wholesale broker, was carried at £112.4m for a 41.0% stake that cost £32.8m. XPT Group, the US broker and Underwriting business, was valued at £57.0m and ATC Insurance Solutions in Australia at £44.6m. Pantheon alone represents roughly 30% of NAV.
What supports the Pantheon mark
The Pantheon valuation has a recent transaction behind it. In April 2026 the group (LSE:BPM) bought a further 2.0% from Pantheon management for £5.5m, implying a value of £275.0m, and the company said Pantheon's Revenue was budgeted to approach £27.7m in 2026 against about £23.8m in 2025. A 41.0% share of £275.0m is close to the carrying value, so the mark is consistent with the price paid. That price was agreed with insiders rather than tested in an open sale, and implies roughly ten times budgeted revenue.
Why concentration matters for returns
Concentration cuts both ways. The company (LSE:BPM) reported an underlying portfolio uplift of about 8.8% in the half, with ATC rising £6.9m, and said compound NAV growth since flotation in 2006 has been 10.9% a year after distributions. Mature holdings have also been converted into cash: £30.8m of share-sale proceeds and Loan repayments arrived in the period, including £9.6m of final Paladin consideration and US$12.1m from XPT.
Cash returns are increasingly part of the proposition. The board intends to pay at least £7.0m in the year to 31 January 2028, including a £2.0m special dividend, taking committed and paid dividends across three years to not less than £28.0m. Group Liquidity was £37.4m with no debt, and the loan book had grown to £46.9m at an average rate of 8.3%.
Factors to watch
Valuations of unlisted minority stakes rely on management assumptions and can move if a large investee's growth slows or deal multiples fall. The company noted that global commercial insurance rates declined by 6% in the second quarter of 2026, although it argued its earlier-stage businesses are less exposed to pricing. Profit before tax fell to £22.8m from £32.1m, and excluding unrealised gains and one-off costs the group made a pre-tax profit of only £2.5m, so reported Earnings remain driven by revaluations.
Operating costs rose to £8.2m, including a £2.6m one-off share-based charge, while portfolio income was £6.5m. A change in performance at Pantheon, XPT or ATC would therefore affect NAV far more than developments elsewhere.
What to watch next
No date has yet been announced for results covering the year to 31 January 2027. Investors will look for any updated Pantheon trading figures, progress on deferred consideration such as the Amiga earn-out linked to 2027 and 2028 performance, and whether new investments like Dauntless, completed in October, begin to broaden the value base beyond the three largest holdings.






Please wait processing your request...